Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
10/2004
10/07/2004WO2004085385A2 Cannabinoid receptor ligands
10/07/2004WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
10/07/2004WO2004085361A1 Bioreductively activated stilbene prodrugs
10/07/2004WO2004084842A2 Inhibitors of cathepsin s
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198980 Selective rxr ligands
10/07/2004US20040198784 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt
10/07/2004US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents
10/07/2004US20040198779 Antiinflammatory agents; adult respiratory distress syndrome
10/07/2004US20040198778 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/07/2004US20040198742 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
10/07/2004US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents
10/07/2004US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
10/07/2004US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine.
10/07/2004CA2519990A1 Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides
10/07/2004CA2519901A1 Bioreductively-activated prodrugs
10/07/2004CA2519401A1 Cannabinoid receptor ligands
10/06/2004EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463697A2 Synthesis of alfa,beta,beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide
10/06/2004EP0915867B1 Thienylcyclohexane derivatives for thienylcyclohexyl synthesis
10/06/2004CN1535264A Arginine derivatives
10/06/2004CN1534023A Heterocyclic compound as dopamine-D3ligand
10/06/2004CN1534016A Calcium acceptor active compound
10/05/2004US6800764 Process for the synthesis of chirally pure beta-amino-alcohols
10/05/2004US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
10/05/2004CA2282834C Novel hexanoic acid derivatives
09/2004
09/30/2004WO2004082677A1 Substituted p-diaminobenzene derivatives
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192943 Nf-kappab inhibitors
09/30/2004US20040192942 Fluorinated pi-bridge second order nonlinear optical chromophores and electro-optic devices therefrom
09/30/2004US20040192941 Chemical compounds
09/30/2004US20040192940 Nonlinear response; electrical communication; mixture of thiophene compound in polymer matrix
09/30/2004US20040192931 Process for the preparation of heterocyclic pentalene derivatives
09/30/2004US20040192758 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/30/2004US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide
09/30/2004US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy
09/30/2004US20040192707 Compounds and methods for the treatment or prevention of Flavivirus infections
09/30/2004US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents
09/30/2004US20040192681 N-acylsulfonamide apoptosis promoters
09/30/2004US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto
09/30/2004CA2519582A1 Substituted p-diaminobenzene derivatives
09/29/2004EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/29/2004EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids
09/29/2004EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/29/2004EP1461323A2 Compounds for the treatment of metabolic disorders
09/29/2004EP1461311A2 Urea derivatives as vr1-antagonists
09/29/2004EP1461303A2 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE b-AMINO-ALCOHOLS
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
09/29/2004EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases
09/29/2004EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
09/29/2004CN1533386A Slfonium salts, methods for their preparation and use therof as photoinitiators for radiation curable systems
09/29/2004CN1533382A 哌嗪衍生物 Piperazine derivatives
09/29/2004CN1533374A Substitutled cyclohexane-1,4-diamine derivatives
09/29/2004CN1532199A Process of 2-methyl-thiophene benzodinitro heterotropilidene
09/29/2004CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
09/29/2004CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
09/28/2004US6797848 Anthracene derivative and organic electroluminescence device using the derivative
09/28/2004US6797731 Resorcinol derivatives
09/28/2004US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
09/28/2004US6797723 Heterocycle substituted diphenyl leukotriene antagonists
09/28/2004US6797719 Osteoporosis; antilipemic agents; anticancer agents
09/28/2004US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain
09/28/2004CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
09/23/2004WO2004081643A1 Lenslet array with polarization conversion
09/23/2004WO2004080996A1 Opioid receptor antagonists
09/23/2004WO2004080990A1 C-glycoside derivatives and salts thereof
09/23/2004WO2004080952A1 Phenylsulfonamide derivatives for treating alzheimer's disease
09/23/2004WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
09/23/2004WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use
09/23/2004WO2004063185A8 Thiophene carboxamides as inhibitors of the enzyme ikk-2
09/23/2004WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004WO2004041217A3 Synthetic lactone formulations and method of use
09/23/2004US20040186321 Method for producing ketones from carboxylic acid anhydrides
09/23/2004US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits
09/23/2004US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia
09/23/2004US20040186147 Sulphonamides for control of beta-amyloid production
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/23/2004US20040186060 [1-(3-cyano-benzyl)-1-([[(5-cyano-thiophen-2-ylmethyl)-carbamoyl]-methyl]-carbamoyl)-3-methanesulfonyl-propyl]-carbamic acid methyl ester; trypsin-like serine protease; for treatment of tumors and metastasis cancer
09/23/2004US20040185378 Stimulus sensitive compound and stimulus sensitive composition containing the same
09/23/2004DE10341535A1 New N,N-disubstituted (hetero)arylsulfonamide derivatives are gamma-secretase inhibitors useful for treatment or prophylaxis of Alzheimer's disease
09/23/2004CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
09/23/2004CA2513791A1 Opioid receptor antagonists
09/22/2004EP1459765A1 6-fluorobicyclo 3.1.0 hexane derivatives
09/22/2004EP1458784A1 3,4-alkylenedioxythiophene compounds and polymers thereof
09/22/2004EP1458719A1 Pyridoquinoxaline antivirals
09/22/2004EP1458705A1 Thiophene derivatives and their use as fragrants
09/22/2004EP1458685A2 Substituted phenyl derivatives
09/22/2004EP1458684A2 Therapeutic heterocycles
09/22/2004EP1458671A1 Prodrugs of excitatory amino acids
09/22/2004EP1458666A1 Improved aromachemicals
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/22/2004EP0805148B1 Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide
09/22/2004CN1531534A 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides